A Future without Heavy Metal Poisoning

About Us Our Science

Every day, communities across the world are being impacted by heavy metal poisoning. Lead paint in homes, leaded water lines, and lead batteries are ever-present. Radioactive material from power plants or a nuclear disaster place much of the world’s population at risk of contamination. When we encounter heavy metals in foods, drugs, medical treatments, or the environment, we risk lifelong health consequences. In all of these cases, safe and effective treatments for people who have been exposed are currently non-existant. Our Focus Areas

HOPO Therapeutics leverages our world-class expertise to address the most pressing unmet needs at the intersection of heavy metals and human health. For us, the term “heavy metals” includes environmental pollutants like lead, cadmium, arsenic, and mercury, as well as the lanthanide elements, many of which are considered critical materials for energy and technology applications. We also include the radioactive actinide elements that drive our nuclear power plants, medical technologies, space vehicles, and nuclear weapons.

We are developing pharmaceuticals designed to treat exposure to heavy metals, beginning with HOPO-101, our leading drug candidate. A clinical-stage oral formulation of our platform drug molecule 3,4,3-LI(1,2-HOPO), it has manifold applications in heavy metal posioning.


General Inquiries

HOPO Therapeutics, Inc.
+1 (510) 239-3180

Please Note at this time we are unable to provide investigational drug products to patients, physicians, or other individuals under any circumstances. Inquiries to that effect may not be considered.


Specific Inquiries

News & Media: media@hopotx.com
Investors: investors@hopotx.com
Partnerships: partnerships@hopotx.com
Legal: legal@hopotx.com
Careers: careers@hopotx.com


Follow us on Twitter @hopotx


Mailing List

Stay up to date with research and development updates, news, and more on our mailing list.